Latest albuminuria Stories
Phase 2 clinical trial of VPI-2690B will enroll patients with kidney damage due to type 1 or type 2 diabetes at multiple centers throughout the United States. Chapel
A drug called atrasentan provides health benefits for patients who have both diabetes and kidney disease.
People with damage in the small blood vessels of the retina and kidneys are at increased risk to develop the most common type of abnormal heart rhythm.
The presence of protein in the urine may be a marker of risk for future cognitive decline in patients with type 2 diabetes and normal kidney function.
For patients with type 2 diabetes, any degree of measurable urinary protein excretion—even in what is considered the normal range—increases their risk of experiencing heart problems.
The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes.
A team of researchers from the United States and Europe has identified a single genetic mutation in the CUBN gene that is associated with albuminuria both with and without diabetes.
ABBOTT PARK, Ill., March 4, 2011 /PRNewswire/ -- Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology.
- A poem in which the author retracts something said in an earlier poem.